目的 探讨流体明胶在颈椎前路手术中控制出血的有效性和安全性。方法 选取我科2015-10至 2016-05期间行颈椎前路手术患者86例, 采用随机数字表法分为试验组和对照组,每组43例。对照组采用常规外科手术方法止血, 试验组术中使用流体明胶止血。通过手术时间、术中出血量、术后引流量评价两组的止血效果。结果 颈椎前路单节段手术试验组应用流体明胶后,其术中出血量(39.4±16.9)ml、手术时间(73.8±13.9)min,均少于对照组术中出血量(46.7±15.9)ml、手术时间(86.3±18.5)min,差异有统计学意义 (P<0.05);试验组术后引流量(6.1±4.2)ml,与对照组(9.3±8.9)ml相比,差异无统计学意义(P>0.05)。结论 流体明胶可减少手术时间及术中出血量,相应降低手术并发症。它是一种安全、有效的止血剂,在颈椎前路手术中有其应用价值。
Abstract
Objective To evaluate the efficacy and safety of SURGIFLO, a hemostatic material,when used to stop active bleeding in anterior cervical operations.Methods Eighty-six patients who had received one-level anterior cervical operation between October 2015 and May 2016 were divided into two groups using the randomized method. SURGIFLO was used for hemostasis in the study group, while the traditional method was used in the control group.Operation time, intraoperative blood loss, postoperative drainage were recorded and compared between the two groups to evaluate the hemostatic effect.Results In anterior cervical operations,the intraoperative blood loss was(39.4±16.9) ml and operation time was(73.8±13.9) mins in the study group, compared with (46.7±15.9) ml and(86.3±18.5) mins in the control group.There was significant difference between the two groups(P<0.05),but there was no significant difference between the study group(6.1±4.2) ml and the control group(9.3±8.9) ml in postoperative drainage (P>0.05).Conclusions In one-level anterior cervical operations, the use of SURGIFLO can shorten the operation time and reduce the intraoperative blood loss and surgical complications.SURGIFLO is a safe and effective hemostatic material in spine surgery.
关键词
颈椎 /
手术 /
止血 /
流体明胶
Key words
cervical vertebrae /
surgery /
hemostasis /
SURGIFLO
中图分类号：
R318.08
R619.1
R681.5
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 宋小虎,徐荣明,孙韶华,等.颈椎前路术后早期硬膜外血肿形成的原因及防治[J].中国骨伤,2013,26(3):197-200.
[2] Goldstein C L, Bains I, Hurlbert R J. Symptomatic spinal epidural hematoma after posterior cervical surgery: incidence and risk factors[J].Spine,2015,15(6):1179-1187.
[3] Gazzeri R, De Bonis C, Galarza M.Use of a Thrombin-gelatin Hemostatic Matrix (Surgiflo) in Spinal Surgery[J].Surg Technol Int,2014,11(25):280-285.
[4] 刘 丰,尹庆水,吴锐辉,等.颈椎前路减压与椎内静脉丛相关的应用解剖学研究[J].中国临床解剖学杂志,2008,26(3):262-264.
[5] 张世庆,赵 雄,鲁景艳,等.可吸收止血材料研究现状与相关技术要求[J].军事医学,2012,36(11):862-866.
[6] Gazzeri R, Galarza M, Alfier A.Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures[J].Surg Technol Int,2012,12(22):49-54.
[7] Gazzeri R, Galarza M, Neroni M, et al.Hemostatic matrix sealant in neurosurgery:a clinical and imaging study[J]. Acta Neurochir(Wien),2011, 153(1):148-154.
[8] 李志辉,张亦工,王彦伟,等.颈椎前路手术中出血原因分析及防治对策[J].中国骨与关节损伤杂志,2013,11,28(11):1044-1045.
[9] Aytan H,Nazik H,Narin R,et al.Comparison of the use of LigaSure,HALO PKS cutting forceps,and ENSEAL tissue sealer in total laparoscopic hysterectomy: a randomized trial[J].J Minim Invasive Gynecol,2014,21(4):650-655.
[10] 陈 斌,王明仓,王惠琴,等.手术室麻醉与下呼吸道感染的相关因素分析[J].中华医院感染学杂志,2014,24(8):2019-2020.
PDF(595 KB)
